| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |